ÂÜÀòÂÒÂ×

Javier Rivela is an experienced executive in the finance and oncology sectors, currently serving as the CEO and co-founder of PANGAEA ONCOLOGY S.A. since October 2010. Additionally, Javier holds a position as a General Member Board at NANOGAP since February 2022. Previously, Javier worked at ING as the European Co-head of S&M Cap Equity Research from November 2000 to March 2009 and as an Equity Research Analyst focused on utilities at Banco Santander for nearly a year. Javier earned an MBA in Finance from San Francisco State University between 1996 and 1998 and a BS in Economics with a focus on Finance from the University of Nevada, Reno from 1992 to 1996.